GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Receivables (2009 - 2026)

Updated

Gsk (GSK) posted Receivables of $10.88 billion for the quarter ended Sep 30, 2026, up 2.0% from $10.67 billion a year earlier and up 6.5% from the prior quarter.

Analysis

Gsk (GSK) Receivables (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk's Receivables came in at $11.61 billion, up 20.2% from the prior year.

  • Annual Receivables shows a five-year compound annual growth rate of 1.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Receivables was $9.65 billion in the year ended Dec 31, 2024 (-10.1%), $10.73 billion in the year ended Dec 31, 2023 (+7.5%), $9.98 billion in the year ended Dec 31, 2022 (-19.0%) and $12.32 billion in the year ended Dec 31, 2021 (+13.4%).
  • Quarterly Receivables has run from a low of $7.83 billion in the quarter ended Jun 30, 2022 to a high of $18.06 billion in the quarter ended Mar 31, 2022 over five years.
  • On a year-over-year basis, Receivables has increased in each of the last seven quarters, with growth averaging 6.1% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables in the past five years was the quarter ended Mar 31, 2022, with growth of 102.4%; the weakest was the quarter ended Mar 31, 2023, with a decline of 53.1%.
  • According to Business Quant data, Receivables for the three prior quarters was $10.21 billion (quarter ended Jun 30, 2026), $10.22 billion (quarter ended Mar 31, 2026) and $11.61 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn 18.99 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 13.82 Bn
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn 15.68 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn 12.49 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn 10.88 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.88 Bn
Jun 30, 2026 10.21 Bn
Mar 31, 2026 10.22 Bn
Dec 31, 2025 11.61 Bn
Sep 30, 2025 10.67 Bn
Jun 30, 2025 10.04 Bn
Mar 31, 2025 9.13 Bn
Dec 31, 2024 9.65 Bn
Sep 30, 2024 9.88 Bn
Jun 30, 2024 9.18 Bn
Mar 31, 2024 8.63 Bn
Dec 31, 2023 10.73 Bn
Sep 30, 2023 10.43 Bn
Jun 30, 2023 8.55 Bn
Mar 31, 2023 8.46 Bn
Dec 31, 2022 9.98 Bn
Sep 30, 2022 8.39 Bn
Jun 30, 2022 7.83 Bn
Mar 31, 2022 18.06 Bn
Dec 31, 2021 12.32 Bn
API Access

Gsk Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GSK&period=max&api_key=YOUR_API_KEY